Eintrag weiter verarbeiten
Designed Antimicrobial Peptides for Recurrent Vulvovaginal Candidiasis Treatment
Gespeichert in:
Zeitschriftentitel: | Antimicrobial Agents and Chemotherapy |
---|---|
Personen und Körperschaften: | , , , , , , |
In: | Antimicrobial Agents and Chemotherapy, 63, 2019, 11 |
Format: | E-Article |
Sprache: | Englisch |
veröffentlicht: |
American Society for Microbiology
|
Schlagwörter: |
author_facet |
Woodburn, Kathryn W. Clemens, L. Edward Jaynes, Jesse Joubert, Lydia-Marie Botha, Alfred Nazik, Hasan Stevens, David A. Woodburn, Kathryn W. Clemens, L. Edward Jaynes, Jesse Joubert, Lydia-Marie Botha, Alfred Nazik, Hasan Stevens, David A. |
---|---|
author |
Woodburn, Kathryn W. Clemens, L. Edward Jaynes, Jesse Joubert, Lydia-Marie Botha, Alfred Nazik, Hasan Stevens, David A. |
spellingShingle |
Woodburn, Kathryn W. Clemens, L. Edward Jaynes, Jesse Joubert, Lydia-Marie Botha, Alfred Nazik, Hasan Stevens, David A. Antimicrobial Agents and Chemotherapy Designed Antimicrobial Peptides for Recurrent Vulvovaginal Candidiasis Treatment Infectious Diseases Pharmacology (medical) Pharmacology |
author_sort |
woodburn, kathryn w. |
spelling |
Woodburn, Kathryn W. Clemens, L. Edward Jaynes, Jesse Joubert, Lydia-Marie Botha, Alfred Nazik, Hasan Stevens, David A. 0066-4804 1098-6596 American Society for Microbiology Infectious Diseases Pharmacology (medical) Pharmacology http://dx.doi.org/10.1128/aac.02690-18 <jats:p> Recurrent vulvovaginal candidiasis (RVVC) is a widespread chronic infection that has a substantial negative impact on work and quality of life. The development of antimicrobial resistance and biofilm formation are speculated to contribute to <jats:italic>Candida</jats:italic> pathogenicity and treatment ineffectiveness. Designed antimicrobial peptides (dAMPs) are chemically modified from endogenous antimicrobial peptides that provide the first line of defense against pathogens. </jats:p> Designed Antimicrobial Peptides for Recurrent Vulvovaginal Candidiasis Treatment Antimicrobial Agents and Chemotherapy |
doi_str_mv |
10.1128/aac.02690-18 |
facet_avail |
Online Free |
finc_class_facet |
Medizin Chemie und Pharmazie |
format |
ElectronicArticle |
fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTEyOC9hYWMuMDI2OTAtMTg |
id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTEyOC9hYWMuMDI2OTAtMTg |
institution |
DE-Zwi2 DE-D161 DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 |
imprint |
American Society for Microbiology, 2019 |
imprint_str_mv |
American Society for Microbiology, 2019 |
issn |
0066-4804 1098-6596 |
issn_str_mv |
0066-4804 1098-6596 |
language |
English |
mega_collection |
American Society for Microbiology (CrossRef) |
match_str |
woodburn2019designedantimicrobialpeptidesforrecurrentvulvovaginalcandidiasistreatment |
publishDateSort |
2019 |
publisher |
American Society for Microbiology |
recordtype |
ai |
record_format |
ai |
series |
Antimicrobial Agents and Chemotherapy |
source_id |
49 |
title |
Designed Antimicrobial Peptides for Recurrent Vulvovaginal Candidiasis Treatment |
title_unstemmed |
Designed Antimicrobial Peptides for Recurrent Vulvovaginal Candidiasis Treatment |
title_full |
Designed Antimicrobial Peptides for Recurrent Vulvovaginal Candidiasis Treatment |
title_fullStr |
Designed Antimicrobial Peptides for Recurrent Vulvovaginal Candidiasis Treatment |
title_full_unstemmed |
Designed Antimicrobial Peptides for Recurrent Vulvovaginal Candidiasis Treatment |
title_short |
Designed Antimicrobial Peptides for Recurrent Vulvovaginal Candidiasis Treatment |
title_sort |
designed antimicrobial peptides for recurrent vulvovaginal candidiasis treatment |
topic |
Infectious Diseases Pharmacology (medical) Pharmacology |
url |
http://dx.doi.org/10.1128/aac.02690-18 |
publishDate |
2019 |
physical |
|
description |
<jats:p>
Recurrent vulvovaginal candidiasis (RVVC) is a widespread chronic infection that has a substantial negative impact on work and quality of life. The development of antimicrobial resistance and biofilm formation are speculated to contribute to
<jats:italic>Candida</jats:italic>
pathogenicity and treatment ineffectiveness. Designed antimicrobial peptides (dAMPs) are chemically modified from endogenous antimicrobial peptides that provide the first line of defense against pathogens.
</jats:p> |
container_issue |
11 |
container_start_page |
0 |
container_title |
Antimicrobial Agents and Chemotherapy |
container_volume |
63 |
format_de105 |
Article, E-Article |
format_de14 |
Article, E-Article |
format_de15 |
Article, E-Article |
format_de520 |
Article, E-Article |
format_de540 |
Article, E-Article |
format_dech1 |
Article, E-Article |
format_ded117 |
Article, E-Article |
format_degla1 |
E-Article |
format_del152 |
Buch |
format_del189 |
Article, E-Article |
format_dezi4 |
Article |
format_dezwi2 |
Article, E-Article |
format_finc |
Article, E-Article |
format_nrw |
Article, E-Article |
_version_ |
1792335358815371269 |
geogr_code |
not assigned |
last_indexed |
2024-03-01T14:42:36.434Z |
geogr_code_person |
not assigned |
openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Designed+Antimicrobial+Peptides+for+Recurrent+Vulvovaginal+Candidiasis+Treatment&rft.date=2019-11-01&genre=article&issn=1098-6596&volume=63&issue=11&jtitle=Antimicrobial+Agents+and+Chemotherapy&atitle=Designed+Antimicrobial+Peptides+for+Recurrent+Vulvovaginal+Candidiasis+Treatment&aulast=Stevens&aufirst=David+A.&rft_id=info%3Adoi%2F10.1128%2Faac.02690-18&rft.language%5B0%5D=eng |
SOLR | |
_version_ | 1792335358815371269 |
author | Woodburn, Kathryn W., Clemens, L. Edward, Jaynes, Jesse, Joubert, Lydia-Marie, Botha, Alfred, Nazik, Hasan, Stevens, David A. |
author_facet | Woodburn, Kathryn W., Clemens, L. Edward, Jaynes, Jesse, Joubert, Lydia-Marie, Botha, Alfred, Nazik, Hasan, Stevens, David A., Woodburn, Kathryn W., Clemens, L. Edward, Jaynes, Jesse, Joubert, Lydia-Marie, Botha, Alfred, Nazik, Hasan, Stevens, David A. |
author_sort | woodburn, kathryn w. |
container_issue | 11 |
container_start_page | 0 |
container_title | Antimicrobial Agents and Chemotherapy |
container_volume | 63 |
description | <jats:p> Recurrent vulvovaginal candidiasis (RVVC) is a widespread chronic infection that has a substantial negative impact on work and quality of life. The development of antimicrobial resistance and biofilm formation are speculated to contribute to <jats:italic>Candida</jats:italic> pathogenicity and treatment ineffectiveness. Designed antimicrobial peptides (dAMPs) are chemically modified from endogenous antimicrobial peptides that provide the first line of defense against pathogens. </jats:p> |
doi_str_mv | 10.1128/aac.02690-18 |
facet_avail | Online, Free |
finc_class_facet | Medizin, Chemie und Pharmazie |
format | ElectronicArticle |
format_de105 | Article, E-Article |
format_de14 | Article, E-Article |
format_de15 | Article, E-Article |
format_de520 | Article, E-Article |
format_de540 | Article, E-Article |
format_dech1 | Article, E-Article |
format_ded117 | Article, E-Article |
format_degla1 | E-Article |
format_del152 | Buch |
format_del189 | Article, E-Article |
format_dezi4 | Article |
format_dezwi2 | Article, E-Article |
format_finc | Article, E-Article |
format_nrw | Article, E-Article |
geogr_code | not assigned |
geogr_code_person | not assigned |
id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTEyOC9hYWMuMDI2OTAtMTg |
imprint | American Society for Microbiology, 2019 |
imprint_str_mv | American Society for Microbiology, 2019 |
institution | DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1 |
issn | 0066-4804, 1098-6596 |
issn_str_mv | 0066-4804, 1098-6596 |
language | English |
last_indexed | 2024-03-01T14:42:36.434Z |
match_str | woodburn2019designedantimicrobialpeptidesforrecurrentvulvovaginalcandidiasistreatment |
mega_collection | American Society for Microbiology (CrossRef) |
physical | |
publishDate | 2019 |
publishDateSort | 2019 |
publisher | American Society for Microbiology |
record_format | ai |
recordtype | ai |
series | Antimicrobial Agents and Chemotherapy |
source_id | 49 |
spelling | Woodburn, Kathryn W. Clemens, L. Edward Jaynes, Jesse Joubert, Lydia-Marie Botha, Alfred Nazik, Hasan Stevens, David A. 0066-4804 1098-6596 American Society for Microbiology Infectious Diseases Pharmacology (medical) Pharmacology http://dx.doi.org/10.1128/aac.02690-18 <jats:p> Recurrent vulvovaginal candidiasis (RVVC) is a widespread chronic infection that has a substantial negative impact on work and quality of life. The development of antimicrobial resistance and biofilm formation are speculated to contribute to <jats:italic>Candida</jats:italic> pathogenicity and treatment ineffectiveness. Designed antimicrobial peptides (dAMPs) are chemically modified from endogenous antimicrobial peptides that provide the first line of defense against pathogens. </jats:p> Designed Antimicrobial Peptides for Recurrent Vulvovaginal Candidiasis Treatment Antimicrobial Agents and Chemotherapy |
spellingShingle | Woodburn, Kathryn W., Clemens, L. Edward, Jaynes, Jesse, Joubert, Lydia-Marie, Botha, Alfred, Nazik, Hasan, Stevens, David A., Antimicrobial Agents and Chemotherapy, Designed Antimicrobial Peptides for Recurrent Vulvovaginal Candidiasis Treatment, Infectious Diseases, Pharmacology (medical), Pharmacology |
title | Designed Antimicrobial Peptides for Recurrent Vulvovaginal Candidiasis Treatment |
title_full | Designed Antimicrobial Peptides for Recurrent Vulvovaginal Candidiasis Treatment |
title_fullStr | Designed Antimicrobial Peptides for Recurrent Vulvovaginal Candidiasis Treatment |
title_full_unstemmed | Designed Antimicrobial Peptides for Recurrent Vulvovaginal Candidiasis Treatment |
title_short | Designed Antimicrobial Peptides for Recurrent Vulvovaginal Candidiasis Treatment |
title_sort | designed antimicrobial peptides for recurrent vulvovaginal candidiasis treatment |
title_unstemmed | Designed Antimicrobial Peptides for Recurrent Vulvovaginal Candidiasis Treatment |
topic | Infectious Diseases, Pharmacology (medical), Pharmacology |
url | http://dx.doi.org/10.1128/aac.02690-18 |